
Silence Therapeutics plc (SLN) earnings
- Healthcare
- NASDAQ
- Market cap$936M
Next report
2027-03-04
In 103 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- -0.09
- -0.12 – -0.102 analysts
- Revenue consensus
- $9.00K
Latest result
9 days ago-112.6%
A surprise beyond ±100% is usually a one-off item or a different basis, so it is left out of averages
Estimate recorded after the release
2026-11-12Q3 FY2026BMO
- EPS
- Reported / estimate-0.24 / -0.11
- Revenue
- — / $113K
Stock reaction
+0.15%
+0.51 pts vs SPY
Session 2026-11-12
Recent quarters
Latest 3 quartersRevenue and stock reaction
Beat in 1 of 2 quarters with a measured stock reaction · beat then fell 1
| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-12 | -0.24 / -0.11 -112.6%‡¶ | — / $113K | +0.15% +0.51 pts vs SPY |
Q2 FY2026 2026-08-10 | -0.26 / -0.14 -87.5%¶ | $137K / $1.17M -88.3%¶ | +29.12% +29.15 pts vs SPY |
Q1 FY2026 2026-05-07 | -0.32 / -0.33 +3.0%¶ | $422K / $1.25M -66.4%¶ | -5.57% -5.26 pts vs SPY |
Reported / estimate
- Q3 FY2026 · 2026-11-12+0.15%EPS-0.24 / -0.11-112.6%‡¶Revenue— / $113K
- Q2 FY2026 · 2026-08-10+29.12%EPS-0.26 / -0.14-87.5%¶Revenue$137K / $1.17M-88.3%¶
- Q1 FY2026 · 2026-05-07-5.57%EPS-0.32 / -0.33+3.0%¶Revenue$422K / $1.25M-66.4%¶
- ‡A surprise beyond ±100% is usually a one-off item or a different basis, so it is left out of averages
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.